The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 2 rounds in the feed, most often at Series A and in Biotech.
Corporationkyowakirin.comRounds from 2025-12-15 to 2026-09-28
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Link Cell Therapies An oncology cell therapy company utilizing its proprietary logic-gating technology to develop next-generation CAR-T therapeutics for solid tumors and hematologic malignancies | Series A ext. Developing, 1 source | $30M | 2026-09-28 | [ PART ] |
Link Cell Therapies An oncology cell therapy company utilizing its proprietary logic-gating technology to develop next-generation CAR-T therapeutics for solid tumors and hematologic malignancies |
Series A Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. |
| $60M |
| 2025-12-15 |
| [ PART ] |